Public trust in the United Arab Emirates’ healthcare system remains among the highest measured anywhere, Gulf News reported, citing the Edelman Trust in Healthcare Report 2026. The report surveyed more than 16,000 people across 16 countries, including roughly 1,000 in the UAE, and it found trust in the country’s health institutions holding firm at a time when confidence in health systems is slipping across much of the world. For a country that treats medical tourism as a deliberate industry, that gap is the whole story.
UAE Trust Scores Lead the Edelman Report
The report put trust in local and national health authorities at roughly 90 per cent, a level that places the UAE among the leading countries for public confidence in health governance. Trust in healthcare companies and providers sat at about 85 per cent, and confidence in the government regulators that oversee medicines, vaccines and medical devices reached a similar level. Gulf News reported that this pattern held across the system rather than concentrating in one part of it, which is the more meaningful signal. Trust that is broad is harder to manufacture than trust in a single flagship hospital.
The sector-by-sector figures fill in the picture. Hospitals drew trust from roughly 90 per cent of respondents, local pharmacies from 85 per cent, and health technology companies from 86 per cent. Pharmaceutical firms recorded 84 per cent, consumer health services 85 per cent, and private health insurance providers about 82 per cent. The nutrition sector sat lower at 77 per cent, still a majority, and the outlier that proves the range. The report said the UAE is also expanding its use of artificial intelligence in health management, from diagnostics to triage, a detail that matters less for its novelty than for what sustained trust lets a system attempt.
Why Trust Is the Real Currency of Medical Tourism
Medical tourism runs on trust more than on price, and the figures explain why the UAE keeps turning up on shortlists for cross-border care. The five drivers that move a patient abroad are better care, the best care, cheaper care, faster care, and care unavailable at home. Trust does not appear on that list, and yet it gates every item on it, because a patient who does not believe the outcome will hold does not book the procedure at all. The calculus is the same whether the case is orthopaedic, oncological or reconstructive. Trust is the precondition. It underwrites the orthopaedic revision, the oncological consultation and the reconstructive follow-up alike. The Edelman figures give Emirati hospitals something a facilitator cannot fabricate: independent evidence that residents themselves trust the system that markets to outsiders.
That distinction matters because the weakest part of the medical tourism trade is the layer of intermediaries who sell visibility rather than trust. A facilitator can buy search rankings and commission testimonials. A facilitator cannot buy a 90 per cent trust score. Regulators earned that number. Marketing did not. For UAE operators, the practical move is to convert trust into published outcomes: infection rates, complication rates, revision rates and readmission rates that an international patient can weigh before flying. Trust measured in a survey is an asset. Trust demonstrated in outcomes data is a moat.
Regulation, Not Marketing, Built the Score
Sustained trust of this kind is the product of regulation, and the UAE’s numbers read as the outcome of consistent oversight rather than a marketing campaign. The regulators clear medicines, vaccines, diagnostics and medical devices, and each clearance is a quiet vote of confidence that later shows up in the hospital figures. A patient who trusts the drugs and the diagnostics trusts the institution that approved them. Accreditation, indemnity and malpractice cover sit behind the same numbers. The government’s investment in medical infrastructure and its adherence to international quality standards are the machinery behind the score. Fix the dull machinery first. The brand follows.
The four standing risks of medical travel are clinical, legal, continuity of care, and the newer geopolitical and logistical exposure that recent airspace disruptions have laid bare. High trust scores speak most directly to the first two. A patient weighing a procedure in Dubai against one at home is weighing perceived clinical safety and the strength of legal redress should the surgery bring a complication or an unmanaged comorbidity, and a system that its own residents trust at 90 per cent answers both questions before they are asked. Continuity of care is the harder problem. It depends on records and follow-up that cross borders, and no trust survey resolves it.
What the UAE Should Do With the Number
A strong trust score is a starting point, not a finish line, and the risk for the UAE is treating the Edelman figures as a destination rather than a foundation. The country sits at the clinical end of the health tourism spectrum, where patients judge a destination on outcomes and safety, and that is the segment where the trust numbers carry the most weight. Cosmetic, cardiac, oncological and reproductive cases all live at that end. Wellness offerings can borrow some of that halo, but the authority the report measures is medical, and it is strongest when applied to accredited hospitals rather than to spa marketing.
The concrete task for Emirati health regulators and hospital groups is to publish the outcomes that justify the trust, so the number becomes a claim an international patient can verify rather than a slogan. Publish the morbidity data. Publish the revision rates. Gulf News reported the trust scores, and the report did not report the outcomes behind them, which is the gap worth closing. A destination that can show the results, and not only the confidence, is the one that converts a survey headline into booked procedures.
